Exploring auxiliary liver transplantation in the era of transplant oncology-A proposal for a new liver splitting program (ALERT-50)
- PMID: 39835850
- DOI: 10.1097/LVT.0000000000000574
Exploring auxiliary liver transplantation in the era of transplant oncology-A proposal for a new liver splitting program (ALERT-50)
Abstract
Total hepatectomy and liver transplantation have emerged as a game-changing strategy in the treatment of several liver-confined primary or metastatic tumors, opening a new era of transplant oncology. However, the expansion of indications is going to worsen the chronic scarcity of organs, and new strategies are needed to enlarge the donor pool. A possible source of organs could be developing split liver transplantation programs. We propose to refer donors aged 18-50 years unsuitable for pediatric patients and donors aged 50-60 years for split evaluation. This will generate new small left lateral grafts that can be used for resection and partial liver segment II-III transplantation with delayed total hepatectomy procedures, based on a national waiting list specifically for non-HCC oncologic patients. Centralized imaging review will streamline the donor-recipient matching process and address organizational challenges. Additionally, adopting an ex situ splitting technique during hypothermic oxygenated machine perfusion could further enhance logistical efficiency and improve graft viability. The proposed protocol (ALERT 50) will therefore promote the development of oncologic indications without affecting the standard waiting list and without competing with urgent or pediatric patients.
Keywords: RAPID; liver transplantation; split; transplant oncology.
Copyright © 2025 American Association for the Study of Liver Diseases.
References
-
- Abreu P, Gorgen A, Oldani G, Hibi T, Sapisochin G. Recent advances in liver transplantation for cancer: The future of transplant oncology. JHEP Reports. 2019;1:377–391.
-
- Sapisochin G, Hibi T, Toso C, Man K, Berenguer M, Heimbach J, et al. Transplant oncology in primary and metastatic liver tumors: Principles, evidence, and opportunities. Ann Surg. 2021;273:483–493.
-
- Vitale A, Cabibbo G, Iavarone M, Viganò L, Pinato DJ, Ponziani FR, et al. Personalised management of patients with hepatocellular carcinoma: A multiparametric therapeutic hierarchy concept. Lancet Oncol. 2023;24:e312–e322.
-
- Wehrle CJ, Fujiki M, Schlegel A, Whitsett Linganna M, Pita A, Kim JK, et al. Update to ‘a contemporary systematic review on liver transplantation for unresectable liver metastasis of colorectal cancer’. Ann Surg Oncol. 2023;31:697–700.
-
- Adam R, Piedvache C, Chiche L, Adam JP, Salamé E, Bucur P, et al. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): Results from a multicentre, open-label, prospective, randomised controlled trial. Lancet. 2024;404:1107–1118.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
